A lipopeptide facilitate induction of Mycobacterium leprae killing in host cells

Area of Science:

• Immunology
• Microbiology
• Cell Biology

Background:

• The direct microbicidal activity of T cells in leprosy is poorly understood.
• Leprosy is caused by Mycobacterium leprae (M. leprae).
• T cells play a crucial role in immune responses against infections.

Purpose of the Study:

• To investigate the direct microbicidal activity of T cells against M. leprae.
• To explore the role of a synthetic lipopeptide (LipoK) from M. leprae in T cell activation and bacterial killing.
• To identify effector molecules involved in T cell-mediated killing of M. leprae.

Main Methods:

• Synthesis of a lipopeptide (LipoK) from M. leprae.
• Activation of human dendritic cells (DCs) infected with M. leprae using LipoK.
• Stimulation of autologous CD4+ and CD8+ T cells with activated DCs.
• Measurement of cytokine production (IL-12, interferon-gamma) and T cell proliferation (CFSE labeling).
• Quantification of effector molecules (granulysin, granzyme B, perforin) in T cells.
• Assessment of M. leprae viability in DCs and in vitro killing assays.

Main Results:

• LipoK activated M. leprae-infected DCs to produce IL-12.
• Activated DCs induced a type 1 immune response in CD4+ and CD8+ T cells, evidenced by interferon-gamma secretion and proliferation.
• LipoK-stimulated T cells produced significant amounts of granulysin, granzyme B, and perforin.
• LipoK mediated T cell-dependent killing of M. leprae within DCs.
• Granulysin and granzyme B directly killed M. leprae in vitro.

Conclusions:

• LipoK can activate T cells to mount an effective immune response against M. leprae.
• T cells, through the production of granulysin and granzyme B, can directly kill M. leprae.
• LipoK holds potential as a therapeutic agent to enhance T cell-mediated killing of M. leprae in leprosy.